- Country: Belgium
- Summary: Levering Van Abiraterone, Anagrelide, Capecitabine, Deferasirox, Everolimus, Fingolimod, Imatinib, Lenalidomide, Sorafenib, Temozolomide En Pomalidomide.
- BET Ref No: 107094927
- Deadline: 11 Oct 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 450000.00
- Notice Type: Tender
- Document Ref. No.: 547211-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Levering van abiraterone, anagrelide, capecitabine, deferasirox, everolimus, fingolimod, imatinib, lenalidomide, sorafenib, temozolomide en pomalidomide.
abiraterone PO
anagrelide PO
capecitabine PO
deferasirox PO
everolimus PO
fingolimod PO
imatinib PO
lenalidomide PO
sorafenib PO
temozolomide PO
Doc - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLevering Van Abiraterone, Anagrelide, Capecitabine, Deferasirox, Everolimus, Fingolimod, Imatinib, Lenalidomide, Sorafenib, Temozolomide En Pomalidomide. - Belgium Tender
The IMELDA VZW, a Government sector organization in Belgium, has announced a new tender for Levering Van Abiraterone, Anagrelide, Capecitabine, Deferasirox, Everolimus, Fingolimod, Imatinib, Lenalidomide, Sorafenib, Temozolomide En Pomalidomide.. This tender is published on BelgiumTenders under BET Ref No: 107094927 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-10-11.
The estimated tender value is EUR 450000.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
